Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Fragile X mental retardation syndrome, the most common cause of hereditary mental retardation, is directly associated with the FMR1 gene at Xq27.3. FMR1 encodes an RNA binding protein and the syndrome results from lack of expression of FMR1 or expression of a mutant protein that is impaired in RNA binding. We found a novel gene, FXR1, that is highly homologous to FMR1 and located on chromosome 12 at 12q13. FXR1 encodes a protein which, like FMR1, contains two KH domains and is highly conserved in vertebrates. The 3' untranslated regions (3'UTRs) of the human and Xenopus laevis FXR1 mRNAs are strikingly conserved (approximately 90% identity), suggesting conservation of an important function. The KH domains of FXR1 and FMR1 are almost identical, and the two proteins have similar RNA binding properties in vitro. However, FXR1 and FMR1 have very different carboxy-termini. FXR1 and FMR1 are expressed in many tissues, and both proteins, which are cytoplasmic, can be expressed in the same cells. Interestingly, cells from a fragile X patient that do not have any detectable FMR1 express normal levels of FXR1. These findings demonstrate that FMR1 and FXR1 are members of a gene family and suggest a biological role for FXR1 that is related to that of FMR1.
Abitbol,
Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain.
1993, Pubmed
Abitbol,
Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain.
1993,
Pubmed Ashley,
FMR1 protein: conserved RNP family domains and selective RNA binding.
1993,
Pubmed Ashley,
Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat.
1993,
Pubmed Bächner,
Enhanced Fmr-1 expression in testis.
1993,
Pubmed Burd,
Conserved structures and diversity of functions of RNA-binding proteins.
1994,
Pubmed De Boulle,
A point mutation in the FMR-1 gene associated with fragile X mental retardation.
1993,
Pubmed Devys,
The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation.
1993,
Pubmed Eichler,
Fine structure of the human FMR1 gene.
1993,
Pubmed Fu,
Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox.
1991,
Pubmed Gahrton,
Cytogenetic mapping of the duplicated segment of chromosome 12 in lymphoproliferative disorders.
1982,
Pubmed Gibson,
The KH domain occurs in a diverse set of RNA-binding proteins that include the antiterminator NusA and is probably involved in binding to nucleic acid.
1993,
Pubmed Gibson,
KH domains within the FMR1 sequence suggest that fragile X syndrome stems from a defect in RNA metabolism.
1993,
Pubmed Green,
Systematic screening of yeast artificial-chromosome libraries by use of the polymerase chain reaction.
1990,
Pubmed Hinds,
Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome.
1993,
Pubmed Jackson,
Cytoplasmic regulation of mRNA function: the importance of the 3' untranslated region.
1993,
Pubmed
,
Xenbase Jänne,
Localization of the 75-kDa inositol polyphosphate-5-phosphatase (INPP5B) to human chromosome band 1p34.
1994,
Pubmed Kiledjian,
Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box.
1992,
Pubmed Mertens,
Clonal chromosome abnormalities in two liposarcomas.
1987,
Pubmed Murty,
Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors.
1992,
Pubmed NULL,
Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium.
1994,
Pubmed Oberlé,
Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome.
1991,
Pubmed Pieretti,
Absence of expression of the FMR-1 gene in fragile X syndrome.
1991,
Pubmed Rastinejad,
Genetic complementation reveals a novel regulatory role for 3' untranslated regions in growth and differentiation.
1993,
Pubmed Rosenberg,
Vectors for selective expression of cloned DNAs by T7 RNA polymerase.
1987,
Pubmed Sachs,
Messenger RNA degradation in eukaryotes.
1993,
Pubmed Sanger,
DNA sequencing with chain-terminating inhibitors.
1977,
Pubmed Singer,
RNA zipcodes for cytoplasmic addresses.
1993,
Pubmed Siomi,
The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.
1993,
Pubmed Siomi,
The pre-mRNA binding K protein contains a novel evolutionarily conserved motif.
1993,
Pubmed
,
Xenbase Siomi,
Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome.
1994,
Pubmed Sonenberg,
mRNA translation: influence of the 5' and 3' untranslated regions.
1994,
Pubmed Studier,
Use of T7 RNA polymerase to direct expression of cloned genes.
1990,
Pubmed Swanson,
Classification and purification of proteins of heterogeneous nuclear ribonucleoprotein particles by RNA-binding specificities.
1988,
Pubmed Turc-Carel,
Breakpoints in benign lipoma may be at 12q13 or 12q14.
1988,
Pubmed Verheij,
Characterization and localization of the FMR-1 gene product associated with fragile X syndrome.
1993,
Pubmed Verkerk,
Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.
1991,
Pubmed Verkerk,
Alternative splicing in the fragile X gene FMR1.
1993,
Pubmed Wilson,
Biochemical evolution.
1977,
Pubmed Yu,
Fragile X genotype characterized by an unstable region of DNA.
1991,
Pubmed
